Uploaded May 2026 | Updated September 2026, 1 week ago
What if gene editing treatments could be delivered directly inside the body—making them faster, more accessible, and less invasive? In this video, Omolivie Eboreime, a bioengineering student at the Harvard John A. Paulson School of Engineering and Applied Sciences, presents his project on developing protein nanoparticles to deliver gene-editing therapies for hemoglobinopathies.
Current treatments, including those based on CRISPR gene editing, often require removing a patient’s stem cells, editing them outside the body, and reinfusing them—an intensive and resource-heavy process. Omar’s approach aims to deliver gene-editing cargo directly into the body, reducing the need for complex procedures and making treatments more accessible—especially in low-resource settings where hemoglobin disorders are most prevalent.
_________________
SEE MORE UNDERGRADUATE STUDENT VIDEOS:
youtube.com/playlist?list=PLtHrXQsUhv80vhJpQUkJSbNM7ZyIyC6jU&si=QxsYywibJ4US_Ljv
SUBSCRIBE TO OUR MONTHLY RESEARCH NEWSLETTER
harvard.us1.list-manage.com/subscribe?u=598d73b470a40f403bba4fb2c&id=318af7d2ea
_________________
VISIT US ON SOCIAL MEDIA
facebook.com/hseas
instagram.com/harvardseas
twitter.com/hseas
linkedin.com/school/1711270/admin/dashboard
_________________
Hashtags: #HarvardSEAS #GeneEditing #CRISPR #Biotech #Bioengineering #HealthcareInnovation #GlobalHealth #Nanotechnology #STEM #StudentResearch #Harvard #Medicine
What if gene editing treatments could be delivered directly inside the body—making them faster, more accessible, and less invasive? In this video, Omolivie Eboreime, a bioengineering student at the Harvard John A. Paulson School of Engineering and Applied Sciences, presents his project on developing protein nanoparticles to deliver gene-editing therapies for hemoglobinopathies.
Current treatments, including those based on CRISPR gene editing, often require removing a patient’s stem cells, editing them outside the body, and reinfusing them—an intensive and resource-heavy process. Omar’s approach aims to deliver gene-editing cargo directly into the body, reducing the need for complex procedures and making treatments more accessible—especially in low-resource settings where hemoglobin disorders are most prevalent.
_________________
SEE MORE UNDERGRADUATE STUDENT VIDEOS:
youtube.com/playlist?list=PLtHrXQsUhv80vhJpQUkJSbNM7ZyIyC6jU&si=QxsYywibJ4US_Ljv
SUBSCRIBE TO OUR MONTHLY RESEARCH NEWSLETTER
harvard.us1.list-manage.com/subscribe?u=598d73b470a40f403bba4fb2c&id=318af7d2ea
_________________
VISIT US ON SOCIAL MEDIA
facebook.com/hseas
instagram.com/harvardseas
twitter.com/hseas
linkedin.com/school/1711270/admin/dashboard
_________________
Hashtags: #HarvardSEAS #GeneEditing #CRISPR #Biotech #Bioengineering #HealthcareInnovation #GlobalHealth #Nanotechnology #STEM #StudentResearch #Harvard #Medicine
